We are live on
!
Find out more
WAS
WESPAC Advisors SoCal Portfolio holdings
AUM
$560M
1-Year Est. Return
37.11%
This Fund
S&P 500
This Quarter
Est. Return
+4.69%
1 Year Est. Return
+37.11%
3 Year Est. Return
+127.08%
5 Year Est. Return
+158.7%
10 Year Est. Return
+511.4%
AUM
$442M
AUM Growth
+$9.74M
(+2.3%)
Cap. Flow
-$900K
Cap. Flow
% of AUM
-0.2%
Top 10 Holdings %
Top 10 Hldgs %
38.64%
Holding
103
New
8
Increased
37
Reduced
41
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust RBA American Industrial Renaissance ETF
AIRR
|
+$9.73M |
| 2 |
Emcor
EME
|
+$8.51M |
| 3 |
Invesco S&P MidCap Momentum ETF
XMMO
|
+$3.29M |
| 4 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$3.27M |
| 5 |
Eaton
ETN
|
+$2.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$12.3M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$9.57M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$3.37M |
| 4 |
ASML
ASML
|
+$2.99M |
| 5 |
Avantis US Small Cap Value ETF
AVUV
|
+$2.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Communication Services | 7.36% |
| 3 | Industrials | 5.99% |
| 4 | Consumer Staples | 5.89% |
| 5 | Consumer Discretionary | 4.8% |
Similar funds
OPWM
HA
MP
NCA
NPPM
KFI
DIM
MCM
WESPAC Advisors SoCal's Q4 2024 Portfolio in Review
As of Q4 2024, WESPAC Advisors SoCal held 103 positions worth $442M, up 2.3% from $432M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
WESPAC Advisors SoCal's Q4 2024 filing shows 8 new, 37 increased, 41 reduced and 4 closed positions. Its largest new stake was First Trust RBA American Industrial Renaissance ETF: 121,970 shares worth $9.4M. The largest sale was Eli Lilly, an estimated $12.3M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Communication Services and Industrials.
- WESPAC Advisors SoCal's largest Q4 2024 buy was First Trust RBA American Industrial Renaissance ETF: 121,970 shares worth $9.4M.
- WESPAC Advisors SoCal added most to State Street SPDR S&P Aerospace & Defense ETF in Q4 2024, an estimated $3.27M increase.
- WESPAC Advisors SoCal's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $12.3M.
- WESPAC Advisors SoCal fully exited Novo Nordisk in Q4 2024, selling an estimated $3.37M.
- WESPAC Advisors SoCal's ten largest holdings make up 39% of its $442M portfolio in Q4 2024.
- WESPAC Advisors SoCal opened 8 new positions and closed 4 in Q4 2024.
- WESPAC Advisors SoCal's portfolio value rose 2.3% quarter-over-quarter to $442M.
Based on WESPAC Advisors SoCal's 13F filing for Q4 2024, filed 27 Jan 2025.